tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
US Market

GlaxoSmithKline Financial Overview

GlaxoSmithKline's market cap is currently ―. The company's EPS TTM is $1.554; its P/E ratio is ―; and it has a dividend yield of 4.46%. GlaxoSmithKline is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $0.49. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 21.76B$ 19.77B$ 22.51B$ 22.39B$ 21.89B
Operating Income$ 7.63B$ 5.67B$ 6.68B$ 6.22B$ 6.29B
EBITDA$ 9.08B$ 9.75B$ 6.22B$ 7.82B$ 7.10B
Net Income$ 4.93B$ 15.34B$ 4.38B$ 5.75B$ 4.64B
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 59.01B$ 60.15B$ 79.10B$ 80.43B$ 79.69B
Total Debt$ 18.02B$ 20.99B$ 24.17B$ 27.15B$ 30.51B
Net Debt$ 12.84B$ 13.11B$ 20.04B$ 20.98B$ 25.92B
Total Liabilities$ 46.21B$ 50.05B$ 57.76B$ 59.62B$ 61.34B
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 4.46B$ 6.42B$ 7.95B-$ 8.02B
Operating Cash Flow$ 6.77B$ 8.34B$ 7.95B$ 8.44B$ 8.02B
Investing Cash Flow
Financing Cash Flow
Currency in USD

GlaxoSmithKline Earnings and Revenue History

GlaxoSmithKline Debt to Assets

GlaxoSmithKline Cash Flow

GlaxoSmithKline Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis